Quarterly Results
Annual Performance Context
For the year-to-date period ended January 31, 2026, Nordson generated net cash provided by operating activities of $140 million, compared to $159 million in the prior year. Free cash flow was $123 million, representing a free cash flow conversion rate of 105% when excluding the non-cash gain. Net income reached $133 million, up from $95 million in fiscal 2025. At quarter end, total shareholders’ equity stood at $3.11 billion, with total assets of $5.96 billion and total debt of roughly $2.0 billion.
Business and Operations Update
Nordson reported a backlog growth of 4% year over year and broad-based order entry momentum, with particular strength in Advanced Technology Solutions. In Industrial Precision Solutions, organic sales growth was driven by balanced demand and “particular strength in Asia Pacific markets”. Medical and Fluid Solutions cited growth in engineered fluid solutions and positive margin improvements. Advanced Technology Solutions benefited from “ongoing growth in electronics dispense systems and recovering demand for x-ray systems”. President Sundaram Nagarajan highlighted that the strong first-quarter performance set the stage well for fiscal 2026. He emphasized growing confidence in the full year, reflected in their increased annual guidance. Nordson invested $18 million in capital expenditures, paid $46 million in dividends, and completed $82 million of share repurchases.
Forward Outlook
For the second quarter of fiscal 2026, Nordson forecasts sales between $710 million and $740 million, with adjusted earnings per diluted share expected from $2.70 to $2.90. For the full fiscal year 2026, the company expects reported sales between $2.86 billion and $2.98 billion, alongside adjusted earnings per share between $11.00 and $11.60.
Performance Summary
Overall, segment performance was led by Advanced Technology Solutions, while Medical and Fluid Solutions delivered higher profitability and Industrial Precision Solutions posted growth. The company raised both quarterly and full-year guidance following these results.